LOS ANGELES--(EON: Enhanced Online News)--Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Psychemedics Corporation (“Psychemedics” or the “Company”) (Nasdaq: PMD) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between February 28, 2014 and January 30, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 3, 2017 lead plaintiff motion deadline.
“preventing other companies from accessing (the) market.”
No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
On January 31, 2017, it was publicized that Psychemedics Brasil Exames Toxicologicos Ltda., Psychemedics' Brazilian representative, will compensate Omega Laboratories, Inc. USA for losses from anticompetitive practices that are used for "preventing other companies from accessing (the) market."
When this information was released to the investing public, shares of Psychemedics fell, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.